Key result
17β-estradiol induced MYLIP expression in male cardiac tissues only, leading to impaired contractile function and augmented myosin regulatory light chain ubiquitination in male cardiomyocytes.
Why the study?
Does 17β-estradiol (E2) treatment affect gene regulation and contractile function in a sex-specific manner in human and mouse cardiomyocytes?
Population
Human cardiac tissues from men and women, and isolated cardiomyocytes from hearts of male and female mice
Comparison
17β-estradiol (E2) treatment vs Untreated/control (implied)
Design
Preclinical
Authors
Loading...
Warrants caution with elevated E2 in males; leaves open MYLIP modulation as sex-specific target to preserve contractility.
Does 17β-estradiol (E2) treatment affect gene regulation and contractile function in a sex-specific manner in human and mouse cardiomyocytes?
17β-estradiol induces MYLIP expression and impairs contractile function specifically in male cardiomyocytes, suggesting a sex-specific mechanism that could influence cardiovascular disease risk in men with elevated E2.
Kararigas et al. (2012) studied Cardiovascular disease. 17β-estradiol (E2) was evaluated on Gene regulation and contractile function. 17β-estradiol induced MYLIP expression in male cardiac tissues only, leading to impaired contractile function and augmented myosin regulatory light chain ubiquitination in male cardiomyocytes.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: